Utility of miRNA biomarkers in patients with acute myocardial infarction (UNIAMI)—results from a prospective pilot study - Scorecard - MDSpire

Utility of miRNA biomarkers in patients with acute myocardial infarction (UNIAMI)—results from a prospective pilot study

  • By

  • Chakradhara Rao S. Uppugunduri

  • Koustav Sarkar

  • Oishi Mukherjee

  • Kaviya Manoharan

  • Iyshwarya B. K

  • Melvin George

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Role of miRNA Biomarkers in Acute Myocardial Infarction Patients: Findings from a Prospective Pilot Investigation (UNIAMI)

At a Glance

CategoryDetail
Condition
Key MechanismsCirculating microRNAs (miRNAs) involved in inflammation, apoptosis, and endothelial dysfunction, as evidenced by the study's findings.
Target Population
Care Setting

Key Highlights

  • highlight_2

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider incorporating miRNA profiling in routine AMI management.

    Monitoring & Follow-up

    • Regularly assess miRNA levels for monitoring disease progression.

    Risks

      Patient & Prescribing Data

      Circulating miRNAs may serve as non-invasive biomarkers for early detection and monitoring of AMI, potentially guiding treatment decisions.

      Clinical Best Practices

      • rationale

      Related Resources & Content

        Original Source(s)

        Utility of miRNA biomarkers in patients with acute myocardial infarction (UNIAMI)—results from a prospective pilot study

        • by Chakradhara Rao S. Uppugunduri, Koustav Sarkar, Oishi Mukherjee, Kaviya Manoharan, Iyshwarya B. K, Melvin George

        • June 11, 2026

        Related Content

        COPD Severity Tied to Life Expectancy

        A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.

        Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies

        Managing Severe Aortic Stenosis in an 89-Year-Old Patient

        In this provider-focused case review, cardiothoracic surgeon Dr. Clinton Kemp discusses the evaluation and treatment of an 89-year-old patient with severe aortic stenosis and multiple comorbidities

        • June 11, 2026

        • 1 min